1

EMORY UNIVERSITY SCHOOL OF MEDICINESTANDARD CURRICULUM VITAE FORMAT

Revised: July 25, 2012

1. Heather Lynn Bloom M.D., FACC

2. Office Address: 2A186 Atlanta VAMC, Suite 111B (do not mail)1670 Clairmont Dr. Decatur, GA 30033Telephone: 404.321.6111 ex 6391Fax: 404.329.2211

Home Address: 2120 Starfire Dr. NEAtlanta, GA 30345 (USE FOR MAIL)Telephone: 678.919.7197Fax: 678.919.7198

3. E-mail address: hbloom@emory.edu

4. Citizenship: US birth day & place: 6/26/1969 Long Beach CA

5. Current Titles and Affiliations:

1. Academic appointments:1. Associate Professor of Medicine, Emory University School of

Medicine, present 2. Assistant Professor of Medicine, Emory University School of

Medicine, July 2005-July 2012

2. Clinical Appointments1. Director of Clinical Electrophysiology, Atlanta VA Medical

center (VAMC), July 2005-present2. Staff physician, Atlanta VAMC, and Grady Memorial

Hospital, July 2005-present

6. Licensures/Boards:1. Medical Licenses

1. ACTIVE: exp 06/112. INACTIVE: CA exp 06/04, MA exp.6/1997

2. Medical Boards1. INACTIVE: Internal Medicine: exp. 12/2010

7. Specialty Boards: 1. Cardiology Board Certification exp 12/20132. Cardiac Electrophysiology Board exp 12/2015

8. Education:

2

1. 1987-1991 University of Vermont, Burlington VT1. BA in Chemistry and English

2. 1989-1990 University of Kent in Canterbury England (jr year abroad)

3. 1991-1996 University of Vermont College of Medicine

9. Postgraduate Training1. 1996-1997 General Surgery Internship Berkshire Medical Center,

Pittsfield MA Dr. P Sadighi2. 1997-2000 Internal Medicine Residency St. Mary’s Medical

Center, San Francisco CA Dr. A Cosintino3. 2000-2003 Cardiology Fellowship University of California, Davis.

Sacramento CA, Dr. W Bommer4. 2003-2005 Cardiac Electrophysiology Fellowship, Emory

University Atlanta GA Dr. J Langberg

10.Committee Memberships:1. National and International:

1. CURRENTI. American Heart Association (AHA) Women in Cardiology

Committee for the Council on Clinical Cardiology 2007-present

II. Heart Rhythm Society (HRS) Women’s Leadership Initiative Task Force 2007-present

III. HRS Women’s Initiative Committee 2007-present

IV. American College of Cardiology (ACC) Women in Cardiology 2005-present

V. ACC Electrophysiology Committee 2009-present

VI. Clinical Events Committee (CEC) Board Chair: 2008- 2013; Sponsor: Biotronik. Study: Galaxy: Multicenter registry (FDA mandated) to record complications of Biotronik ICD leads. Review cases for complications and classify per FDA designations. Minimum 2000 patients, 5 years.

VII. Clinical Events Committee Board Chair: 2008-2013 Sponsor: Biotronik Study: Celestial: Multicenter post-approval registry to record and review complications of Biotronik left ventricular pacing leads and classify per FDA designations. Minimum 2000 patients, 5 years

3

VIII. Clinical Events Committee Board Chair:2010-presentpresent; Sponsor: TyRX Pharma. Study: Centurion. Multicenter, randomized trial looking at infection rates in CRT-D recipients after generator exchange

IX. Clinical Events Committee Board Chair: 2010-present; Sponsor: TyRX Pharma. Study: Citadel. Multicenter randomized trial looking at infection rates in ICD recipients after generator exchange.

2. PASTI. Heart Rhythm Society (HRS) Membership Committee

2007-2009

II. Clinical Events Committee Board Member 2007-2009. Sponsor: Biotronik. Study: REPLACE. Multicenter prospective trial looking at pre-specified complications rates after cardiac rhythm management device generator exchanges.

III. Clinical Events Committee Board Chair 2009-2010 Sponsor: TyRX pharma. Study: COMMAND. Multicenter retrospective observational study examining infection rates after cardiac rhythm management device generator exchanges.

2. Regional and StateI. Sudden Cardiac Arrest Association (SCAA) – Medical

Advisor for the Greater Atlanta Area 2009-presenta. AED donation ceremony November 2009b. Annual Meeting April 17, 2010c. Gwinnett County Summer Safety Fair June 5,

2010 10 am to 3 pm community lectures on SCA and CPR

d. Community SCA presentation May 20, 2011 e. "Friends and Family" CPR/AED talk to AAHL

(Atlanta adult hockey league) June 2011

II. Metro-Atlanta Pacing Society (MAPS) 2007-presenta. Annual lectures for EP communityb. Currently undergoing incorporation and 501-C3

status

3. Institutional- Emory University or Atlanta VAMC

4

1. Faculty Life Committee Emory University 2006-present, secretary 2007-2009

2. Internal Review Board (IRB) Emory University 2007-present3. Root Cause Analysis Committee VAMC 2007-present

I. Completed: Committee for faculty Salary Determination Atlanta VAMC 2006-2007, reconvened 12/2011 for 1 session

11.Manuscript reviewer1. Medical Journals

1. HEART 2005-present2. Pacing and Clinical Electrophysiology (PACE) 2005-present3. Journal of Clinical Electrophysiology (JCE) 2005-present4. Heart Rhythm 2005- present5. American Geriatric Cardiology Society 2006- present6. International Journal of COPD 2007- present7. Circulation- CIRC EP 2007-present8. Cardiology Research and Practice 2010-present9. Combination Products in Therapy

12. Honors and Awards1. February 2008- VAMC Certificate of Appreciation for VAMC Federal

Women’s Program2. June 2008- Excellence in Teaching Award from Department of

Medicine Cardiovascular Medicine Fellowship Program3. June 2009- Excellence in Teaching Award from Department of

Medicine Cardiovascular Medicine Fellowship Program4. June 2011- Excellence in Teaching Award from Department of

Medicine Cardiovascular Medicine Fellowship Program

13.National and International Society Memberships:1. American College of Cardiology (ACC): 2001- present

1. ACC Women in Cardiology Section 2005-present2. Fellow, American College of Cardiology 2006-present

2. Heart Rhythm Society (HRS) 2003-present3. Electrophysiology Society (EPS) 2006-present4. American Heart Association (AHA) 2007-present

14.Research Focus: Research interests include risk factors for sudden cardiac death and atrial fibrillation, including the complex interactions of oxidative stress with arrhythmia and the relationship of diastolic dysfunction with arrhythmia. Secondary interests include CRM (cardiac rhythm management) device infection risk reduction and the relationship between autonomic dysfunction and arrhythmia.

15.Patents:

5

1. Marker for Arrhythmia Risk: 111828-00156, VA ID#07-129

16.Grant Support:1. Active Support 8/15/2004 to current

1. Federally Funded: NIH-R01 HL077398, Primary PI Dr. Barry London. Co-PI for Emory site (2 sites only) Dr. Heather Bloom Awarded Direct: $446,440. Percent of time: 5% GRADE: Genetic Risk Assessment of Defibrillator Events. Adult patients with depressed ejection fraction referred for internal cardioverter-defibrillator (ICD) placement will undergo 5+ year follow up for arrhythmia events and provide DNA samples for multiple evaluations of polymorphisms that lead to increased risk of arrhythmias. Inclusive dates: 2007-2012 (follow up will continue past funding; application for additional NIH grant funding by primary site is currently undergoing revisions)

2. Private foundation funded I. TyRX Pharmaceuticals: Sponsor two multicenter trials: I

am the site PI for Atlanta VAMC. VA contract for payment per visit.

a. Centurion: inclusive dates: 2009 to current (predicted 2013): Prospective observational trial examining the Aigis™ antimicrobial envelope effects on cardiac rhythm management device infections in Cardiac Resynchronization Therapy (CRT) devices. Contract: $5265 Percent of time:1%

b. Citadel: inclusive dates 2009 to current (predicted 2013): Prospective observational trial examining the Aigis™ antimicrobial envelope effects on cardiac rhythm management device infections in Internal-Cardioverter Defibrillator (ICD) infections. Contract $5265 Percent of time: 1%.

c. Sorin Group (ELA Medical). OPTION:2008-2011 Multicenter trial, I am the site PI for Atlanta VAMC. VA contract for payment per visit. Do ICD patients benefit from dual chamber ICD therapy- comparing ICD therapies with the PARAD algorithm. Contract: $3592. This study is in the process of being closed out.

2. Prior Support1. Emory University Research Committee (URC): Award

amount: $30,000 Personal Grant for me, PI. Percent of time, 2% July 2007-June 2008. Observational clinical study examining co morbidities for mortality in ICD patients. (See CV, publication # 13 )

6

2. Grant- Pfizer Pharmaceuticals. Award Amount: $75,000. Dr. Samuel Dudley, PI, Dr. Heather Bloom, Co-PI 2006-2010. (Sole PI after Dr. Dudley departed 2007) Single center trial. Atorvastatin Therapy for the Prevention of Atrial fibrillation (STOPAF) published 12/2010 (See CV publication # 12); Percent of time 2%.

3. Education Grant: 2007. $10,000. Sponsor: St. Jude Medical. This was an unlimited educational grant designed to support EP training for fellows and staff entirely at my discretion. Funds have been allocated to date for EP textbooks and educational conferences.

4. RIGHT (Rhythm ID Going Head To Head) – Boston Scientific, Multicenter trial. Co-PI, site PI for Atlanta VAMC. Assessed arrhythmia discrimination in Guidant and Medtronic devices. Completed 2008. Funds went to Dr. Zafari; do not have data on award amount. Percent of time 1%.

17.Clinical Service Contributions 2005-Present1. Electrophysiology consult service:- 12 months per year2. General Cardiology consult service:1.5 months per year3. Cardiac Intensive Care Unit: 1.5 months per year4. Electrophysiology Clinics: 4 - ½ day clinics per week5. Pre-ICD clinic: ½ day per week6. Pacer/ICD clinic: 3 days per week7. Invasive procedures/surgeries: 4 days per week (3.5 days VAMC, 1

day Grady Hospital)8. Non-invasive procedures (cardioversions, tilt table tests): 1-4 per week

18.Formal Teaching1. General recurrent teaching: 2005 - present

1. House staff: formal lectures for residents, fellows, medical students during service months

2. Clinical Cardiology Fellow: a series of 3 formal talks per week, 12 months a year

3. VA cardiology Fellow weekly noon conference: EGC for the boards, Monday 12-1 pm

4. VA house staff noon conference: SVT or VT or Devices, 2-5 x per year

5. Atlanta VAMC staff conferences: ECG and arrhythmia q. o. month

2. Medical Student Teaching (formal lectures):1. Emory University Cardiology Series: Arrhythmia April 6,

2009

7

2. Emory University Cardiology Series: Arrhythmia April 5, 2010

3. Emory University Cardiology Series: Arrhythmia April 4, 2011

3. Residents/ House Staff1. Grady Clinical Core Lecture Cardiology- Ventricular

Tachycardia 3/10/20052. VA Clinical Core Lecture Cardiology- Ventricular

Tachycardia 3/22/20053. Grady Grand Rounds- Cardiac Rhythm Management

Devices 11/10/20054. Grady Clinical Core Lecture Cardiology- Ventricular

Tachycardia 3/09/20065. VA Clinical Core Lecture Cardiology- Ventricular

Tachycardia 3/10/20066. Grady Grand Rounds- Cardiac Rhythm Management

Devices 9/7/20067. VA Clinical Core Lecture Cardiology- Ventricular

Tachycardia 3/20078. Grady Clinical Core Lecture Cardiology- Supraventricular

Tachycardia 4/3/20079. VA Clinical Core Lecture Cardiology- Supraventricular

Tachycardia 4/10/200710. Grady Grand Rounds- Cardiac Rhythm Management

Devices 9/6/200711. VA Clinical Core Lecture Cardiology- Ventricular

Tachycardia 2/28/2008

12. Grady Grand Rounds- Cardiac Rhythm Management Devices 8/28/2008

13. VA Clinical Core Lecture Cardiology- Wide Complex Tachycardia 4/7/2009

14. Grady Grand Rounds- Cardiac Rhythm Management Devices 8/27/2009

15. ENT surgical residents Grand Rounds: Atrial fibrillation 6/14/2010

16. Grady Grand Rounds- Cardiac Rhythm Management Devices 10/28/2010

17. VA noon conference- Atrial Arrhythmias and Ablation 10/29/2010

18. Clinical Core VA lecture house staff: Electrocardiograms 8/23/2011

4. Cardiology Fellows1. General Cardiology Fellows Core Lecture: Syncope

3/21/2007

8

2. General Cardiology Fellows Core Lecture: Supraventricular arrhythmias 9/8/2008

3. General Cardiology Fellows Core Lecture: Supraventricular arrhythmias 9/8/2008

4. General Cardiology Fellows Core Lecture: Supraventricular arrhythmias 10/2/2009

5. General Cardiology Fellows Core Lecture: Ventricular arrhythmias 12/7/2009

6. General Cardiology Fellows Core Lecture: Syncope 11/3/2010

7. General Cardiology Fellows Core Lecture: Bradycardia 10/17/2011

8. General Cardiology Fellows Core Lecture: Syncope 12/17/2011

5. Other Local1. Electrophysiology Journal Club Emory University School of

Medicine 8/15/2007 REPLACE study2. ICD support group for Veterans: Atlanta VAMC 6/2007-

ongoing meets every 4-8 weeks with topics and discussion for patients

6. National and International1. Invited Physician Panel Discussion: Hospital Acquired

Infections: HRS Denver CO 5/13/20102. LIVE Webinar, Cardiac Rhythm Management Device

Infections; presented online and recorded 6/21/20103. Update on Device Infections: TyRX Pharma, presented

during HRS scientific sessions May 6, 1 pm

19.Supervisory Teaching:1. Residency program per above2. Other Mentoring:

1. Premedical students:I. Summer intern 2011: Jesus Arroyo

II. Summer intern 2012: Jessica Parker2. Medical Student Summer Intern: William Jang, Summer

2006, resulted in American College of Cardiology Oral Abstract Presentation

3. Lisa Williams, RN 2007-2010 mentored involving research, resulted in Lisa’s participation on several research studies, and two publications in EP Lab Digest (Peer reviewed publication not listed on PubMed: CV citations # 27 B, C)

4. Clinical Research Coordinators

9

I. Irfan Shukrullah MD, 2006-2008 now in Internal Medicine (IM) residency University of Il at Chicago, applying for cardiovascular fellowship. Multiple abstract publications

II. Radihka Gadesam MD, 2007-2009, now in IM residency Morehouse College of Medicine

III. Ravindar Reddy MD 2007- present (multiple abstracts and manuscripts accepted as a trainee for 2 programs)

5. Fellows:I. Samantha Svarczkopf MD, 2006-2007 Cardiology Fellow,

EP fellowship University of Louisville 2009-2011 Columbus Regional Hospital, Indiana

II. Richard Vest MD, 2007-2009, Cardiology Fellow, EP fellowship MSSC 2009-2011. Upstate Cardiology, Greenville SC

20.Lectureships, Seminar Invitations and Visiting Professorships:1. External Invited Lectures

1. Birmingham VAMC: Electrophysiology Studies: 6/19/20062. Cognis-Teligen educational lecture for Allied Professionals

8/18/20083. South Atlantic Society for Allied Professionals: End of Life

issues with Cardiac Rhythm Management Devices September 2011

4. Women in Electrophysiology 2011; Annual conference for women in electrophysiology. Invited faculty speaker case presentations September 2011

2. University Sponsored CME Courses1. Emory University IM board review course (Annual); 2006-

20112. Emory Crawford-Long Hospital Management Course: Rate

Control of Atrial Fibrillation April 20, 20073. Heart Failure Management Symposium 2008 (Morehouse

School of Medicine) Debate: Implant ICDs in all Heart Failure Patients according to LV Ejection Fraction Only: Protagonist. Panel Discussion on Heart Failure

21.Other Activities1. Other Teaching:

1. Lecturer, Fellows Conference, Dates. Prepared and presented multiple lectures and accompany visual materials at monthly fellows conferences. (Titles listed on teaching portfolio.)

2. Formal Hospital Protocols Written:1. Protocol for Use of IV beta-blockers on telemetry 20072. Protocol for CRM Device Deactivation 20073. Protocol of initiation of Dofetilide 2008

10

4. Protocol for use of Precidex 20103. Consultant:

1. New Mentor, 6/2010 to present Reviewed and edited clinical management and treatment guidelines on the following topics for use by hospitalists and house staff:

I. Aortic Stenosis: June 2010II. Aortic Regurgitation: October 2010III. Ventricular Fibrillation: April 2011IV. Cholesterol Guidelines for Patients: July 2011V. Post-operative atrial fibrillation: August 2011VI. Post-PCI guidelines: August 2011

22.Bibliography:1. Published and accepted Research Articles (clinical, basic science,

other) in peer reviewed refereed journals:1. Sabapathy R, Bloom HL, Amsterdam EA. Right precordial and

posterior chest leads do not increase detection of positive response in electrocardiogram during exercise treadmill testing. Am J Cardiol. 2003 Jan 1;91(1):75-7. PubMed PMID: 1205576.

2. Bloom H, Glatter K. Arrhythmia of the month by Kriby et al. Cardiovasc Electrophysiol 2002 Jul;13(7):732; author reply 732.PubMed PMID:12139303

3. Bloom H, Chiamvimonvat N, Whitcomb C, Glatter K. Malignant vasovagal syncope. Circulation. 2003 June 17;107(23)2987-8. PubMed PMID: 12814986

4. Bloom H, Heeke B, Leon A, Mera F, DeLurgio D, Beshai J, Langberg J; Chronic Renal Insufficiency and the Risk of Infection from Pacemaker or Defibrillator Surgery. Pacing ClinElectrophysiol. 2006 Feb; 29(2):142-5. PubMed PMID: 12814986

5. Bloom H, Shukrullah I, Cuelar J, Lloyd M, Dudley Jr, S, Zafari M, Long-term survival after Successful In-hospital Arrest Resuscitation. Am Heart J. 2007 Mayl153(5):831-6. PubMed PMID: 16492298

6. Neuman R, Bloom HL (co First Authors), Shukrullah I, Darrow LA, Kleinbaum D, Dudley SC. Oxidative Stress markers are associated with persistent atrial fibrillation. Clinical Chemistry June 28, 2007:53;1652-57 PubMed PMID: 17452161

7. Endeshaw YW, Bloom HL, Bliwise DL. Sleep disordered breathing and Cardiovascular disease in the Bay Area Sleep Cohort. Sleep 2008 April 31(4):563-568 PubMed PMID: 17599958

8. Ali B, Bloom HL, House D, Veledar E, Norval R, Dudley SC, Zafari AM. Automated External Cardioversion Defibrillaton Monitoring in Cardiac Arrest: A Randomized Trial. Trials 2008 9:36. PubMed PMID: 18523216

11

9. Bloom HL; Shukrullah I, Cuellar J, Veledar E, Gutmann R, London B, Dudley jr. SC. Statins Decrease Oxidative Stress and ICD Therapies. Cardiol Res Practic. 2010; 2010:253803. Epub 2010 Mar 25. PubMed PMID: 20369058.

10. Bloom HL Constantin L, Dan D, De Lurgio DB, El-Chami M, Ganz LI, Gleed KJ, Hackett FK, Kanuru NK, Lerner DJ, Rasekh A, Simons GR, Sogade FO, Sohail MR. Incidence of Implantation Success and Infection in Cardiovascular Implantable Electronic Device Procedures with the Aigis rx Anti-bacterial Envelope. Pacing Clin Electrophysiol. 2011 Feb; 34(2): 133-42. doi: 10.1111/j.1540-8159-2010.02931.x.Epub 2010 October 13. PubMed PMID: 20942819

11. Shukrullah I, Jang W, Vest RN, Dudley SC, Bloom HL. Left Atrial Enlargement Correlates with Inflammation and Oxidative Stress in Patients at HighRisk for Atrial Fibrillation. Journal of Clinical and Experimental Cardiology. August 29, 2010 PMID

12. Negi S; Shukrullah I; Veledar E; Bloom HL; Jones D; Dudley S; Statin Therapy for the Prevention of Atrial Fibrillation Trial (SToP AF trial). J Cardiovasc Electrophysiol. 2011 Apr;22(4):414-9. doi: 10.1111/j.1540-8167.2010.01925.x. Epub 2010 Oct 13. PMID: 20946227

13. Vest RN, Gadesam RR; Wijayawardana SR; Valadri RR; Zafari M; Easley K; Bloom HL. Association of Elevated Body Mass Index with Appropriate ICD Therapy in a Veteran Patient Population with Heart Failure and Implantable Cardioverter- Defibrillators. The Journal of Innovations in Cardiac Rhythm Management, 2 (2011), 512–518.

14. Refaat MM; Lubitz SA; Makino S; Islam Z; Frangiskakis MF; Mehdi H; Gutmann R; Zhang ML; Bloom HL; MacRae CA; Dudley SC; Shalaby AA; Weiss R; McNamara DM; London B;Ellinor PT. Genetic Variation in the Alternative Splicing Regulator, RBM20, is associated with Dilated Cardiomyopathy. Heart Rhythm. 2011 Oct 17 [Epub ahead of print] PubMed PMID: 22004663

15. Blanco RR; Austin H; Vest RN; Valadri R; Li W; Lassegue B; Song Q; London B; Dudley SC; Bloom HL; Zafari AM. The Association of ACEI/D genotype and AT1-A1166C polymorphism with implantable cardiac defibrillator interventions in patients with heart failure. ACCEPTED: Journal of Heart Failure July 2012

2. Manuscripts submitted, under review1. Blanco RR, Amer M; Darrow LA; Bloom HL; Dudley SC MS

TITLE: A Predictive Model of Postoperative Atrial Fibrillation with Cardiothoracic Surgery resubmitted World Journal of Cardiovascular Medicine 11/2011

12

2. Bloom HL. A novel technique for avoiding venoplasty during totally occluded subclavian or SVC veins during cardiac rhythm management device implantation Submitted: Heart Rhythm (12/2011)

3. Valadri R; Veledar E; Mengistu A; Gadesam R; Bali C; Wood C; McIlraith T; Ginn K; Kohler S; McCall S; Hamilton S; Onwuanyi A; Bloom HL; El Chami M; Delurgio DB. The Association of High Risk Berlin Score with Nocturnal Sudden Cardiac Death in Systolic Heart Failure Patients with Implantable Cardioverter Defibrillator: Submitted for Young Investigator Award Heart Rhythm Society Annual Scientific Sessions 2012

3. Invited Editorials1. Bloom, H.L. Concise review of atrial fibrillation: treatment update

considerations in light of AFFIRM and RACE. Clin Cardiol. 2004 Sep;27(9):495-500. PMID: 15471159

2. Bloom HL Beyond Beta-blockade: nerve growth factor and arrhythmia. Heart Rhythm, 2007 Sept;4(9):1214-5 2007 July 4 PMID 1776567

4. Review Articles1. Bloom HL Differential Entrainment Pacing, two great paces that

pace great together. Heart Rhythm 2009 April:6(3):501-2 PMID 19324310

2. Bloom HL Treatment of Ventricular Tachycardia, consider ablation sooner. F1000 Medicine Reports 2009, 1:71 PMID 20948708

3. Jordan RJ; Bloom HL Prevention of bacterial infections in patients with cardiac implantable devices; old traditions meet new technology. The Journal of Innovations in Cardiac Rhythm Management 1 (2010):63-71

5. Abstracts:1. Glatter KA; Ackerman MJ, Van Hare GF; Bloom H; Dorostkar

PC, Scheinman MM. Type and reproducibility of symptoms in a genotyped congenital Long QT patients. JACC 2002:39 (supplement A):117A

2. Sabapathy R; Bloom H; Lewis W; Amsterdam E. Right Precordial and posterior chest leads do not augment detection of ischemia in the exercise electrocardiogram. Circulation Supplement (104);3474, 2001

13

3. Bliwise DL; Bloom HL; Endeshaw YE; Ansari FP. Sleep Apnea and Cardiovascular disease in the Bay Area Sleep Cohort. AGS 2004

4. Bloom HL; Langberg JJ Preoperative BNP levels Correlate with Degree of Fractional Improvement in Hall walk in Patients undergoing Cardiac resynchronation therapy (CRT). JACC 2005:45 (Supplement B1);321B

5. Bloom H; Heeke B; Leon A; Mera F; De Lurgio D; Beshai J, Langberg JJ. Renal Insufficiency, a potent and previously unrecognized risk for infection after device implantation. Heart Rhythm 2005:4(5s)

6. Newman RB; Bloom HL; Darrow LA; Kleinbaum D; Dudley jr. SC; Oxidative Stress but not inflammatory markers predict persistent atrial fibrillation. Heart Rhythm May 2006: 3(5):S302-3

7. Jang W; Dudley jr. SC; Bloom HL; Left Atrial Enlargement Correlates with Inflammation and Oxidative Stress in Patients at high risk for atrial fibrillation. JACC 2007:49(9) Supplement A;819-7

8. Jackson C; Ali B; Bloom H; Zafari AM; Automatic External Cardiac Defibrillation Monitoring in cardiac Arrest. Presented J Willis Hurst Internal Medicine Residency Program Annual Research Day, Emory University School of Medicine 1/18/2007.

9. Bloom H; Shukrullah I; Cuellar J; Lloyd M; Dudley SC; Zafari AM. Long term survival after in-hospital cardiac arrest. Heart Rhythm 2007:4(5S) p03-7

10. Ali B; Bloom H; Veledar E; Norval R; Dudley jr. SC; Zafari AM. Automated External Cardioversion Defibrillation Monitoring in Telemetry (moderated poster session, Best Original Resuscitation Science). Circulation, Oct 2007; 116: II_927.

11. Shukrullah I; Cuellar J; Veledar E; Bloom H; Dudley jr. SC. Plasma Redox state and the recurrence of atrial fibrillation. JACC March 11, 2008; 51: A1-A34

12. Bloom HL; Shukrullah I; Cuellar J; Veledar E; Guttmann R; London B; Dudley jr. SC. Statins decrease oxidative stress and ICD events. Heart Rhythm 45(5) S May 2008.

13. Bloom HL; Fan TM Using Ventricular Sense Response™ to optimize Biventricular Pacing in a patient with no atrial lead. Heart Rhythm 5(5S) May 2008.

14. Ali B; Vest RN; Bloom HL; Veledar E; House D, Norvel R, Dudley SC jr; Zafari AM. Automated External Cardioversion/Defibrillation Monitoring in telemetry Patients: Poster presentation 14th World Conference on Heart Disease July 2008. Published online: http://www.cardiologyonline.com/wchd08/final_prog_sun.htm

14

15. Fangiskakis J; Niles K; Grimley S; Guttmann R; Bloom HL; Dudley SC; Ellinor P; Shalaby A; Weiss R; Saba S; MacNamere A. African-Americans with Congestive Heart Failure have more arrhythmias than Caucasians independent of the SCN5A S1103Y Genotype. Circulation 2008;118:S_718.

16. Vest RN; Bloom HL. African-Americans with Nonischemic cardiomyopathy have more ventricular arrhythmias than Caucasians and have higher levels of inflammatory and oxidative stress markers. ACC GA Chapter Annual Scientific Sessions, November 22, 2008

17. Vest RN; Gadesam R; Valadri R; Bloom HL. Obesity does not increase risk of ventricular arrhythmias in a veteran patient population with ICDs. Keystone Symposium: Feb 25, 2009 Vancouver BC

18. Vest RN; Gadesam R; Valadri R; Bloom HL; Effect of Gender on Patients with systolic heart failure: women have more ventricular arrhythmias than men. JACC 2009;53:A136

19. Refaat M; Frangiskakis JM; Grimley S; Gutmann R, Bloom HL; Dudley SC, Ellinor P; Shalaby A; Weiss R; McNameara D; London B. The β2-Adrenergic Gln27 polymorphism is associated with increased ventricular arrhythmias in patients with severe heart failure (moderated poster session) May 15, 2009. Heart Rhythm vol. 6(5S): MP 02-01

20. Bloom HL; Vest RN; Blanco R; Valadri R: Shukrullah I; Gutmann R; London B; Dudley SC, Zafari AM. African-Americans with cardiomyopathy have more ventricular arrhythmias than Caucasians and have higher levels of inflammatory and oxidative stress markers (Oral Presentation). Heart Rhythm 6(5S) May 2009 S16-7

21. Vest RN; Blanco RR, Valadri RR, Gutmann R; Dudley SC; London B, Zafari AMl; Bloom HL; African Americans with Heart Failure, Racial differences in ICD therapies and inflammatory and oxidative stress markers. European Society of Cardiology- Heart Failure Annual Scientific Sessions; Nice, France; May 30, 2009.

22. Vest RN; Blanco RR: Valadri RR; Gutmann R; Dudley SC; London B; Zafari AM; Bloom HL; Influence of elevated BMI on ventricular arrhythmias in a veteran patient population with heart failure and internal cardioverter-defibrillators. European Society of Cardiology- Heart Failure Annual Scientific Sessions; Nice, France; May 30, 2009.

23. Lerner D; Bloom HL; Constantin L; Delurgio DB; Hackett K; Kanuru NK; Rasekh A; Sogade FO. Aigis Rx Anti-bacterial envelope retrospective registry results. TCT Sept 22, 2009.

24. Blanco RR: Vest RN; Valadri R; Li W; Austin H; Song Q; Dudley SC; London B; Bloom HL; Zafari AM. The relationship

15

between the AGTR1-A1166C polymorphism with implantable cardiac defibrillator therapies in patients with chronic heart failure Circulation. 2009;120:S1468.

25. Mehdi H; Frangiskakis JM; Grimley S; Gutmann R; Bloom HL; Dudley SC, Ellinor PT; Shalaby A; Weiss R; Saba S; McNamara DM; London B. NOS1AP is associated with arrhythmias in a heart failure population with severe LV dysfunction Circulation. 2009;120:S571-2.

26. Aleong RG, Halder I, Bloom HL, Dudley SC, Ellinor PT, Saba S, Shalaby A, Weiss R, London B. 2010. Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias [Abstract]. Heart Rhythm. Vol. 7, no. 5, Supplement: S427

27. Valadri R; Bloom H; Gadesam R; Delurgio D; Jones D; Bhadriraju S. Obstructive Sleep Apnea is associated with worsened oxidative stress and treatment resistance in atrial fibrillation. Journal of Cardiac Failure 16(8) S1: S61 August 2010.

28. Valadri RV; Gadesam R; McLraith T; Onwuanyi A; Bloom HL; Delurgio DB. Diastolic Dysfunction can predict ventricular arrhythmias in Sarcoidosis. Emory University, September 2010

29. Bavikati VV; Jordan JR; Manocha P; Langberg JL; Vest RN; Bloom HL; Lloyd MS. Underlying coronary artery disease potentiates the antiarrhythmic effect of dofetilide on atrial fibrillation. JACC 2010; 55;A8.E80.

30. Refaat M; Mehdi H; Halder I; Islam Z ;Friehling M; Liu J; Gutmann R; Bloom HL ; Dudley SC; Ellinor P, Shalaby AA; Weiss, R; Saba S; McNamara DM; London B. Variations in Cardiac Calcium-Handling Genes are Associated with Ventricular Arrhythmias in Patients with Severe Cardiomyopathy presented: Heart Rhythm Society, May 4, 2011.

31. Valadri R; Gadesam R; Bali C; McIlwraith R; Onwuanyi A; Delurgio D, Bloom H. Cardiac Sarcoidosis presenting as cardiac dyssynchrony and failure of cardiac resynchronization therapy. JMCC 51(3): S20; September 2011.

32. Valadri R; Gadesam R; Bloom H; Olatidoye A; Onwuanyi A. Heart Failure with preserved ejection fraction complicating peripartum; phenotypic variant of peripartum cardiomyopathy. JMCC 51(3): S30; September 2011.

33. Refaat MM; Benhayon D; Batal O; Purohit A; Halder I, Mehdi H, Gutmann, R; El Masry H; Bloom HL; Dudley SC; Ellinor PT; Shalaby AA; Weiss R; McNamara D, Saba S; London B. Fragmented Wide QRS on a 12-Lead Electrocardiogram Increases the Risk of Ventricular Arrhythmias in Patients with Severe Systolic Dysfunction. Presentation: , American Heart Association Annual Scientific Sessions; November 13, 2011.

16

34. Dai S; Mehdi H; Halder I; Singh M; Gutmann R; Bloom HL; Dudley SC; Ellinor PT; Shalaby A; Weiss R; Nerbonne JM; London B; Splice Site Insertion in FGF12 is Associated with Ventricular Arrhythmias in Heart Failure Patients. Presentation: American Heart Association Annual Scientific Session; November 14, 2011.

35. Valadri R; Veledar E; Gadesam R; Cross JA; Cardona S, Strayhorn G; Bloom HL; Delurgio DB; Butler J; Ofili E; Onwuanyi A. Is there a mortality benefit with Renin-Angiotensin System ( RAS) inhibition in African Americans (AA) with heart failure with preserved ejection fraction (HFPEF)? Accepted for American College of Cardiology Annual Scientific Sessions March 2012, Chicago IL

36. .Valadri R; Veledar E; Gadesam R; Cross JA; Cardona S, Strayhorn G; Bloom HL; Delurgio DB; Butler J; Ofili E; Onwuanyi A. Effect of Angiotensin Receptor Blocker (ARB) therapy on long term survival in African Americans (AA) with Heart Failure (HF) Accepted for American College of Cardiology Annual Scientific Sessions March 2012, Chicago IL

37. Valadri R; Veledar E; Gadesam R; Cross JA; Cardona S, Strayhorn G; Bloom HL; Delurgio DB; Butler J; Ofili E; Onwuanyi A. The Association of High Risk Berlin Score with Nocturnal Sudden Cardiac Death in Systolic Heart Failure Patients with Implantable Cardioverter Defibrillators Accepted for Heart Rhythm Society Annual Scientific Sessions May 9-12 2012

38. Valadri R; Veledar E, Gutmann R; Bloom HL; Dudley SC London B "Evidence for the Disparity in Implantable Cardioverter Defibrillator Efficacy in Patients above 60 Years and below 60 Years" has been accepted for presentation at the 16th Annual Scientific meeting of the Heart Failure Society of America (September 9-12, Washington State Convention Center, Seattle, WA).- ACCEPTED

23.Symposium contributions:1. Heart Failure Management Symposium 2008, Morehouse School of

Medicine Debate: Implant ICDs in all heart failure patients according to LVEF only; Panel Discussion

24.Manuals, videos, computer programs and other teaching aids1. Clinical Electrophysiology Manual for EP staff (80 pages) 20062. What You Should Know About Your Defibrillator (patient hand out; 7

pages) 20073. Basics for the ICD patient (ppt talk) 20074. What you should know about your Defibrillator: DVD for patients with

cardiology staff 2007

17

5. EP and ECG questions for Cardiology Fellows Inservice Exam, 2008; 6. EP and ECG questions for Cardiology Fellows Inservice Exam 2009; 7. EP and ECG questions for Cardiology Fellows Inservice Exam 2010; 8. EP and ECG questions for Cardiology Fellows Inservice Exam 2011;9. Cardiac Rhythm Management and device infections in the modern era

2011

25.Other presentations1. Comparison of Markers of Oxidative Stress Present in Left Atrial

Appendage Tissue from Subjects With and Without Atrial Fibrillation” Irfan Shukrullah MBBS; Heather L. Bloom MD; Thomas Vassiliades MD; Jonathan Langberg MD; David Vega MD; David Harrison MD; Samuel Dudley MD, PhD. . Poster Presentation at EMORY University 3/17/2006.

26.Other Publications:1. Bloom HL: Interview with ?. Strategies for Preventing Cardiac Device

Implant Infections: Interview with Heather Bloom, MD. EP Lab Digest 12/03/2009.

2. Williams L; Bloom HL. Moderate Sedation Pioneers for Atrial Fibrillation Ablations EP Lab Digest 9/10/2010

3. Bloom HL. Clinical and Industrial News. EP Lab Digest 5/2/201027.Letters To The Editor

1. Bloom, H, Glatter, K. J Arrhythmia of the month by Kirby et al.J Cardiovasc Electrophysiol. 2002 Jul;13(7):732; author reply 732.

28.Presentations at National/International Conferences1. Oral Presentation HRS 2005: Bloom H Renal Insufficiency: A Potent

and Previously Unrecognized Risk for Infection after Device Implantation

2. Poster Presentation ACC 2005: Bloom H: Preoperative BNP Levels Correlate with Degree of Fractional Improvement in Hall walk in Patients Undergoing Cardiac Resynchronization Therapy (CRT)

3. Oral Presentation HRS 2007. Bloom H Long Term Survival After In-Hospital Cardiac Arrest

4. Poster Presentation HRS 2008: Bloom H Statins Decrease Oxidative Stress and ICD Events

5. Poster Presentation HRS 2008: Bloom H Using Ventricular Sense Response™ to optimize Biventricular Pacing in a Patient with no Atrial lead

6. Oral presentation European Society of Cardiology Heart Failure Annual Scientific Session, Nice France Vest RN, Bloom H African Americans with Heart Failure, Racial Differences in ICD Therapies and Inflammatory and Oxidative Stress Markers

7. Oral Presentation HRS 2009. Bloom H African-Americans with Cardiomyopathy Have More Ventricular Arrhythmias than Caucasians

18

and Have Higher Levels of Inflammatory and Oxidative Stress Markers Genetic Syndromes in SCD: Brugada and Other Factors

8. Oral Presentation HRS 2009. Gleva MJ for the REPLACE investigators: Complication Rates Associated with Pacemaker and Implantable Defibrillator Generator Replacement: Results from the REPLACE Registry: Late Breaking Clinical Trials Thursday, May 14, 2009, 10:30 a.m. - 12:00 p.m

9. Oral Presentation TCT 2009: Bloom H AIGISRx Anti-bacterial Envelope Retrospective Registry Results

10.Oral Presentation HRS 2011: Bloom H CRMD infections, old techniques meet new technology

29.Online, Peer Reviewed Electronic Publications1. Bloom HL. Severe dyspnea on exertion. Cardiosource Web Site,

American College of Cardiology Foundation and Elsevier, Inc. July 2003. http://www.accardio.org/cs/casestudies/initPres.asp?studyID=381. July 16, 2003

2. Bloom, HL Faculty of 1000 Medicine, 29 May 2008 http://www.f1000medicine.com/article/id/1108934

3. Bloom, HL Faculty of 1000 Medicine, 26 August 2008 http://www.f1000medicine.com/article/id/1119287

4. Bloom, HL Faculty of 1000 Medicine, 17 October 2008 http://www.f1000medicine.com/article/id/1124221

5. Bloom, HL Faculty of 1000 Medicine, 16 January 2009 http://www.f1000medicine.com/article/id/1148137

6. Bloom HL Faculty of 1000 Medicine, 19 April 2009 http://www.f1000medicine.com/article/id/1158807

7. Bloom HL: Faculty of 1000 Medicine, 9 Nov 2009 http://www.f1000medicine.com/article/id/1163698/evaluation

8. Bloom HL: Faculty of 1000 Medicine 6 Jan 2010 http://f1000medicine.com/article/id/1347963/evaluation

9. Bloom HL: Faculty of 1000 Medicine 17 Feb 2010 http://www.f1000medicine.com/article/id/1968975/evaluation

10.Bloom HL: Faculty of 1000 Medicine X May 2010 http://www.f1000medicine.com/article/id/3185964/evaluation

11.Bloom HL: Faculty of 1000 Medicine 9 July 2010 http://www.f1000medicine.com/article/id/3900956/evaluation

12.Bloom HL: Faculty of 1000 Medicine 15 November 2010 http://f1000.com/6119956

13.Bloom HL: Faculty of 1000 Medicine 7 February 2011 http://f1000.com/8159959

14.Bloom HL: F1000 23 June 2011 http://f1000.com/1146695715.Bloom HL: F1000 11 October 2011 http:// f1000 .com/13357297 16.Bloom HL: F1000 19 January http:// f1000 .com/13474956 17.Bloom HL: F1000 14 April 2012. http://f1000.com/14264112

19

18.